Retraction
Tripartite motif‑containing 14 regulates cell proliferation and apoptosis in cervical cancer via the Akt signaling pathway
Paper Information
Record ID:
47700
Author(s):
Journal:
Publication Date:
October 26, 2020
Retraction Date:
September 25, 2023
(2.2 years years ago)
Subjects:
Institutions:
- Medical Center of Cervical Diseases, Obstetrics and Gynecology Hospital, Fudan University, Shanghai 200011, P.R. China
- Department of Gynecology, Obstetrics and Gynecology Hospital, Fudan University, Shanghai 200011, P.R. China
- Department of Clinical Laboratory, Shanghai No. 8 People's Hospital, Shanghai 200235, P.R. China
Country:
🇨🇳 ChinaArticle Type:
Publisher:
Spandidos
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Retraction Details
Citations (13)
13
Total Citations3
Post-Retraction(23.1%)
10
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
0
Within 30 days
3
Within 1 year
0
After 2+ years
155
Days since retraction (latest)
Advances in the antitumor mechanisms of tripartite motif-containing protein 3
Wei Teng, Yuanguo Ling, Zongwei Liu et al. (9 authors)
Journal of Cancer Research and Clinical Oncology
Open Access
Published: Feb 2024
2 citations
2 citations
155 days after retraction
Multipronged regulation of autophagy and apoptosis: emerging role of TRIM proteins
Nuzhat Ahsan, Mohd Shariq, Avadhesha Surolia et al. (6 authors)
Cellular & Molecular Biology Letters
Open Access
Published: Jan 2024
25 citations
25 citations
113 days after retraction
Tripartite motif family – its role in tumor progression and therapy resistance: a review
Yongqi Zhang, Ying Guan, Shuxiang Wang et al. (5 authors)
Current Opinion in Oncology
Published: Jan 2024
113 days after retraction
Role of the tripartite motif (TRIM) family in female genital neoplasms
Tianyu Liu, Jian Chen, Jinjie Wu et al. (8 authors)
Pathology - Research and Practice
Published: Sep 2023
2 citations
2 citations
16 days before retraction
TRIM14 Overexpression Induces Chemoresistance and Malignant Behaviors of Hepatocellular Carcinoma Cells by Activating the STAT3/HIF-1α Pathway
Weiqi Xu, Lihong Zhuang, Hongxu Zhu et al. (6 authors)
International Journal of Molecular Sciences
Open Access
Published: Aug 2023
9 citations
9 citations
47 days before retraction
Targeting TCF19 sensitizes MSI endometrial cancer to anti-PD-1 therapy by alleviating CD8+ T cell exhaustion via TRIM14-IFN-β axis
Xinyue Ma, Qiuman Wang, Chenggong Sun et al. (16 authors)
Cell Reports
Open Access
Published: Aug 2023
10 citations
10 citations
55 days before retraction
Neglected PTM in animal adipogenesis: E3-mediated ubiquitination
Hongbiao Ran, Chunyan Li, Ming Zhang et al. (5 authors)
Gene
Published: Jun 2023
4 citations
4 citations
100 days before retraction
Intricate confrontation: Research progress and application potential of TRIM family proteins in tumor immune escape
Junjie Gu, Jingyi Chen, Shuaixi Xiang et al. (5 authors)
Journal of Advanced Research
Open Access
Published: Feb 2023
17 citations
17 citations
235 days before retraction
The roles and targeting options of TRIM family proteins in tumor
Yuxin Zhang, Wenzhou Zhang, Lufeng Zheng et al. (4 authors)
Frontiers in Pharmacology
Open Access
Published: Sep 2022
19 citations
19 citations
360 days before retraction
In vitro assessment of roles of PPP1R14B in cervical and endometrial cancer
Nan Xiang, Tao Chen, Xiaoli Zhao et al. (4 authors)
Tissue and Cell
Published: May 2022
7 citations
7 citations
482 days before retraction
TRIM21 inhibits the osteogenic differentiation of mesenchymal stem cells by facilitating K48 ubiquitination-mediated degradation of Akt
Jiaqi Xian, Daochen Liang, Chengyi Zhao et al. (5 authors)
Experimental Cell Research
Published: Jan 2022
13 citations
13 citations
616 days before retraction
The translational values of TRIM family in pan-cancers: From functions and mechanisms to clinics
Zhao Guo, Chuan Liu, Xin Wen et al. (6 authors)
Pharmacology & Therapeutics
Published: Apr 2021
44 citations
44 citations
880 days before retraction
Knockdown of TRIM11 suppresses cell progression and apoptosis of cervical cancer cells via PI3K/AKT pathway.
Wenfeng Liu, Zuoli Wu, Lijuan Wang et al. (6 authors)
American Journal of Translational Research
Published: Jan 2021
10 citations
10 citations
997 days before retraction
Quick Stats
Total Citations:
13
Years Since Retraction:
2.2 years
Open Access:
Yes
Last Checked:
Jul 24, 2025